# A Phase 1 Study of Single-dose Subcutaneous E6011 in Japanese Healthy Adult Male Subjects

> **NCT02146261** · PHASE1 · COMPLETED · sponsor: **Eisai Co., Ltd.** · enrollment: 32 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** E6011
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02146261
- **Lead sponsor:** Eisai Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2013-12
- **Final completion:** 2014-04
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2014-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02146261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02146261, "A Phase 1 Study of Single-dose Subcutaneous E6011 in Japanese Healthy Adult Male Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02146261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*